Articles

Friday Pearls

Friday Pearls

Zinc in the AMD News

Friday, July 13, 2007

This week’s Pipex pharmaceutical news release would have one think that high intake of a newly patented form of zinc, 'Z-monocys' (a monocysteine complex ), invented by ophthalmologist David Newsome, could be the elixir of life or at the very least, the panacea for the dry AMD patient. Possibly, but more probably not!

Provocative Science-in-Fiction

Friday, July 06, 2007

Carl Djerassi, PhD, father of the birth control pill, developer of antihistamines, developer of environmentally benign pesticides, Stanford teacher of world class chemists, former president of Syntex, novelist, prolific playwright and one of the few Renaissance men in twentieth-century science, acknowledged our mutual interest in tear film chemistry by sending me a lovely inscribed gift of one of his books titled The Futurists and Other Stories. One particularly inventive story from this book, The Dacriologist, is perfect beach reading for our ophthalmic and optometric-focused Friday Pearl subscribers. 

Fishing for Answers

Friday, June 29, 2007

"Nearly every ocular disease has a genetic component. That’s why genomics and molecular biology are changing the way eye disease is diagnosed and treated. Gene-based approaches will play a prominent role in disease prevention in the future." Charles Wormington, O.D. PhD, Associate Professor of Biophysics and Optometry, Pennsylvania College of Optometry.

How Does the Genomics Revolution Affect the Eye Care Professional?

Friday, June 22, 2007

"Nearly every ocular disease has a genetic component. That’s why genomics and molecular biology are changing the way eye disease is diagnosed and treated. Gene-based approaches will play a prominent role in disease prevention in the future." Charles Wormington, O.D. PhD, Associate Professor of Biophysics and Optometry, Pennsylvania College of Optometry.

Age Related Macular Degeneration: The First Year

Friday, June 15, 2007

The June 2007 issue of Archives of Ophthalmology reviews the recently published book, The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed, by Dan Roberts - the visually impaired founder of MD Support.

LAST II: Responders vs. Nonresponders

Friday, June 08, 2007

The objective of Stuart Richer, OD, PhD's original Lutein Antioxidant Supplementation Trial (LAST) was to determine whether specific dietary interventions increased macular pigment optical density (MPOD) and visual function in patients with atrophic age-related macular degeneration (ARMD). His objective with the recent LAST II study was to discern which of the specific characteristics that increase MPOD differentiate a supplement responder from a nonresponder.

Randomized Clinical Trials and Micronutrients

Friday, June 01, 2007

Scientists are being asked to consider whether the drug model for research relying strictly on randomized clinical trials (RCTs) is actually the most appropriate evidence-based research model for nutrients, including dietary supplements.

Silent Spring

Friday, May 25, 2007

"There was once a town in the heart of America where all life seemed to live in harmony with its surroundings." First sentence, Rachel Carson's Silent Spring   The book took its title from the opening chapter, a vision of a rural community rendered silent in springtime - its habitual birdsong silenced by the mass poisoning of all the birds. 

Multivitamin Use and Risk of Prostate Cancer

Friday, May 18, 2007

A study published in the May 16 Journal of the National Cancer Institute (JNCI) on “Multivitamin Use and Risk of Prostate Cancer in the National Institutes of Health–AARP Diet and Health Study” concludes that there was no association observed between multivitamin use and risk of localized prostate cancer. However, the researchers found an increased risk of advanced and fatal prostate cancers among men reporting excessive use of multivitamins (more than seven times per week) when compared with never users.

Proteomics, Exercise and Inflammation

Friday, May 11, 2007

Today’s column addresses questions from our recent ASCRS Eyes on Fire lecture. Proteomic science is changing the way many gerontologists think about inflammation, the aging process and degenerative diseases. The term proteomics was coined as an analogy to genomics, the study of genes. Understanding the structure and function of each protein and the complexities of protein-protein interactions is becoming critical to the development of effective diagnostics, disease treatments and more importantly, degenerative disease prevention including eye disease.  

Pages:  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47